BioCorRx Inc. (BICX) Establishes New NDCs Ahead of LUCEMYRA Transition
BioCorRx Inc. (BICX) set up new NDCs for LUCEMYRA and its generic versions, aiming to finish the commercial transition by year-end. The company also started a Phase 1 study for BICX104 and secured new U.S. patent protection.
